Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).
Dementia & Chronic Disease – Practical Advice
Head and Neck Lumps
The NLCSP – Incidental Chest Findings – What Now? – A Focus on Interstitial Lung Abnormalities
Why are LAMAs Useful in Asthma Management
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland